Toshiba America Medical Systems of Tustin, CA, and the Mayo Foundationfor Medical Education and Research of Rochester, MN, have settledlitigation relating to an MRI artifact-suppression patent grantedto Mayo in 1987. Mayo filed the suit against Toshiba
Toshiba America Medical Systems of Tustin, CA, and the Mayo Foundationfor Medical Education and Research of Rochester, MN, have settledlitigation relating to an MRI artifact-suppression patent grantedto Mayo in 1987. Mayo filed the suit against Toshiba last yearin U.S. District Court in Milwaukee (SCAN 2/14/96).
Both parties declined to disclose the terms of the settlement,although they did say that Mayo has licensed the patent to fourother companies besides Toshiba. The patent covers a techniquethat eliminates artifacts caused by flow, motion, and phase aliasingby using a series of saturation pulse sequences that are interleavedwith MRI pulse sequences.
Mayo is also involved in a dispute with Picker Internationalof Cleveland over the patent, according to Mayo attorney WayneBabler of Quarles & Brady in Milwaukee.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 2
July 25th 2025In the second of a multi-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, share their perspectives on remote MRI safety protocols for ensuring screening accuracy and adherence to conditional implant guidelines as well as a rapid and effective response to adverse events.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 2
July 23rd 2025In the second part of a multi-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, discuss key sequences for abbreviated breast MRI and how it stacks up to other breast cancer screening modalities.
Chest CT for Post-COVID-19 Abnormalities: Nine Takeaways from a Multi-Society Consensus Statement
July 22nd 2025Developed by 21 thoracic radiologists, the new international consensus statement addresses appropriate indications, scan acquisition and keys to reporting for the use of chest CT imaging in evaluating for residual lung abnormalities from COVID-19.